Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors

Figure 5

The protein expression levels SETDB1 in normal and cancer tissues. (a) SETDB1 protein expression data in 44 normal tissues. (b) The percentage of cancer patients (maximum 12 patients) with high and medium protein expression level (HPA018142). (c) Immunohistochemistry results of SETDB1 protein assessed in brain glioma, papillary adenocarcinoma, endometrium adenocarcinoma, urinary bladder carcinoma, and lymph node Hodgkin’s disease. (d) The differences in protein expression levels of SETDB1 in different tumors and normal tissues from TCGA.

(a)

(b)

(c)

(d)